Loading...
Loading...
By Miriam Bello - Tue, 06/29/2021 - 12:53
COFEPRIS’s recent update is expected to spur innovation on drug therapies and encourage investment on innovation.
https://mexicobusiness.news/tag/marco-ruggiero
More Health
By Miriam Bello - Tue, 06/01/2021 - 15:05
Changes to medicines purchasing schemes brought savings but also several problems.
By Miriam Bello - Fri, 04/30/2021 - 14:17
Experts agree the health industry will play a key role in helping the country brave both its health and economic crises.
By Miriam Bello - Fri, 04/16/2021 - 09:23
Chiesi’s priorities focus on propelling innovation in Mexico by breaking bureaucratic barriers that slow progress.
By Mónica López - Mon, 02/15/2021 - 11:59
Industry players unite to solve the current health situation in Mexico. Mexico Health Summit covers the government’s centralized purchasing scheme.
By Jan Hogewoning - Wed, 01/27/2021 - 21:07
Director General of Chiesi Mexico, Marco Ruggiero explains how medicine purchasing schemes have impacted the industry and Chiesi's place as a provider
By Miriam Bello - Wed, 01/27/2021 - 13:41
Industry players unite to solve the current health situation in Mexico. Mexico Health Summit covers the government’s centralized purchasing scheme.
By Miriam Bello - Wed, 07/08/2020 - 16:44
The healthcare sector grabbed the spotlight in Mexico before COVID-19, as public entities faced medicine shortages. Here is what happened.
By Miriam Bello - Mon, 04/20/2020 - 17:11
Marco Ruggiero explains how good work and practices have translated on being the first pharmaceutical company on having B Corp ertification
By - Wed, 06/05/2019 - 18:30
Chiesi Group is a pharmaceutical manufacturer founded in Italy in 1935.